GDUFA Research Outcomes
Topical Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the topical route, including topical dermatological products.
- 
                        Topical Semisolid Drug Product Critical Quality Attributes (Q3 Characterization) with Relevance to Topical Bioequivalence
                        Murthy, Narasimha 
- 
                        Characterizing Failure Modes And Critical Quality (Q3) Attributes Of Semi-Solid Topical Drug Products
                        Murthy, Narasimha 
- 
                        Evaluating Quality (Q3) Attributes And Potential Failure Modes For Topical Semisolid Drug Products
                        Murthy, Narasimha 
- 
                        Equivalence of Locally-Acting Drug Products
                        Luke, Markham 
- 
                        FDA’s Regulation of Drug Products Used by Dermatologists and Dermatologic Surgeons
                        Luke, Markham 
- 
                        History of Dermatology and Dermatologists at the U.S. Food and Drug Administration
                        Luke, Markham 
- 
                        FDA Science and Regulation for the Physician Scientist
                        Luke, Markham 
- 
                        FDA Update: FDA and Dermatologic DEIA
                        Luke, Markham 
- 
                        Innovation and Topical Generic Drug Science: A Case of Targeted and Planned Innovation
                        Luke, Markham 
- 
                        Generic Drugs and Dermatology: Bioequivalence and Access Equity
                        Luke, Markham